You just read:

Intezyne to Showcase Novel Cancer Resistance Pathway Inhibitor IT-139's Potential in Gastric Cancer at ChinaBio® Partnering Forum 2018 in Suzhou, PRC

News provided by

Intezyne Technologies, Inc.

Apr 16, 2018, 08:30 ET